AbCellera Biologics Statistics
Total Valuation
ABCL has a market cap or net worth of $1.08 billion. The enterprise value is $730.14 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ABCL has 299.34 million shares outstanding. The number of shares has increased by 1.57% in one year.
| Current Share Class | 299.34M |
| Shares Outstanding | 299.34M |
| Shares Change (YoY) | +1.57% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 22.90% |
| Owned by Institutions (%) | 27.66% |
| Float | 203.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 30.50 |
| Forward PS | 34.89 |
| PB Ratio | 1.11 |
| P/TBV Ratio | 1.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.10, with a Debt / Equity ratio of 0.15.
| Current Ratio | 10.10 |
| Quick Ratio | 8.48 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -16.81% and return on invested capital (ROIC) is -12.71%.
| Return on Equity (ROE) | -16.81% |
| Return on Assets (ROA) | -10.43% |
| Return on Invested Capital (ROIC) | -12.71% |
| Return on Capital Employed (ROCE) | -17.81% |
| Revenue Per Employee | $59,270 |
| Profits Per Employee | -$288,049 |
| Employee Count | 596 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -33.25M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.70% in the last 52 weeks. The beta is 0.70, so ABCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +21.70% |
| 50-Day Moving Average | 4.93 |
| 200-Day Moving Average | 3.63 |
| Relative Strength Index (RSI) | 32.58 |
| Average Volume (20 Days) | 4,783,387 |
Short Selling Information
The latest short interest is 55.16 million, so 18.43% of the outstanding shares have been sold short.
| Short Interest | 55.16M |
| Short Previous Month | 53.20M |
| Short % of Shares Out | 18.43% |
| Short % of Float | 27.14% |
| Short Ratio (days to cover) | 9.69 |
Income Statement
In the last 12 months, ABCL had revenue of $35.33 million and -$171.68 million in losses. Loss per share was -$0.58.
| Revenue | 35.33M |
| Gross Profit | -147.49M |
| Operating Income | -229.28M |
| Pretax Income | -204.93M |
| Net Income | -171.68M |
| EBITDA | -232.66M |
| EBIT | -229.28M |
| Loss Per Share | -$0.58 |
Full Income StatementBalance Sheet
The company has $495.67 million in cash and $142.22 million in debt, giving a net cash position of $353.45 million or $1.18 per share.
| Cash & Cash Equivalents | 495.67M |
| Total Debt | 142.22M |
| Net Cash | 353.45M |
| Net Cash Per Share | $1.18 |
| Equity (Book Value) | 964.04M |
| Book Value Per Share | 3.26 |
| Working Capital | 626.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$104.55 million and capital expenditures -$48.56 million, giving a free cash flow of -$153.11 million.
| Operating Cash Flow | -104.55M |
| Capital Expenditures | -48.56M |
| Free Cash Flow | -153.11M |
| FCF Per Share | -$0.51 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -649.05% |
| Pretax Margin | -580.11% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ABCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.57% |
| Shareholder Yield | -1.57% |
| Earnings Yield | -15.84% |
| FCF Yield | -14.13% |
Analyst Forecast
The average price target for ABCL is $7.75, which is 115.28% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.75 |
| Price Target Difference | 115.28% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 43.24% |
| EPS Growth Forecast (5Y) | -26.67% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ABCL has an Altman Z-Score of 1.43 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.43 |
| Piotroski F-Score | 3 |
